Measles is a severe and infectious disease triggered by a virus. Early symptoms of the disease are fever, red eyes, runny nose, and cough. Later, red spots and tiny rashes are observed on skin. Measles is spread by a virus belonging to the paramyxovirus family, genus Morbillivirus. The diameter of virus is 120 nm to 250 nm. Measles only occurs in humans and not in animals. The measles virus first infects only the respiratory tract, then spreads throughout the body.
Measles is one of the leading causes of death among children. According to the World Health Organization (in 1980), measles caused an estimated 2.6 million deaths each year. In 2015, approximately 134200 people died globally due to measles. MMR vaccines (combination of measles, mumps, and rubella vaccine) is given at the time of birth to prevent measles. It is an immunization vaccine and combination of live attenuated viruses of three diseases. In 2015, about 85% of world’s children received one dose of measles vaccine by birthday through routine health services.
The Centers for Disease Control and Prevention (CDC) recommended two doses of measles vaccine. One dose of measles vaccine is 93% effective, while two doses of vaccine is 97% effective in preventing measles. The first dose of measles vaccine is recommended at 12 months through 15 months of age, and the second dose at 4 years through 6 years. One dose of vaccination is recommended to adults who did not get vaccinated in childhood.
The measles vaccine market has been segmented based on product, application, end-user, and region. In terms of product, the market has been categorized into two types: mumps measles rubella vaccine, live (MMR-II) and mumps measles rubella and varicella virus vaccine (Proquad). MMR II (measles, mumps, and rubella virus vaccine live) is a live virus vaccine for vaccination against measles (rubeola), mumps, and rubella (German measles). MMR II is a sterile lyophilized preparation of live virus vaccine containing measles virus, mumps virus, and rubella virus. Proquad is the sterile lyophilized combination of live virus vaccine containing measles, mumps, rubella and varicella virus.
Based on application, the global measles vaccine market has been divided into pediatric vaccines and adult vaccines. Pediatric vaccines are given in two doses. First at the age of 15 months and second is before the age of six. Pediatric vaccines are more effective than adult vaccines. Adult vaccine is only single dose vaccine. According to CDC, adults born in 1957 or later who have not been vaccinated or have not had measles are recommended one dose of measles vaccine. The pediatric vaccines segment is estimated to account for major share of the global measles vaccine market.
In terms end-user, the global measles vaccine market has been segmented into hospitals, clinics, and vaccination centers. Measles vaccines are cost effective and easily available.
Geographically, the global measles vaccine market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to hold high market share of the global measles vaccine market owing to high awareness about the disease and vaccination in the region. Asia Pacific is expected to expand at a high CAGR during the forecast period driven by government initiatives for immunization against measles. Latin America and Middle East & Africa are expected to show significant growth during the forecast period. Growth in the regions is driven by low cost of vaccination. The cost of measles vaccination is less than US$ 1 in these regions.
Key players in the global measles vaccine market are MedImmune, Johnson & Johnson Private Limited, Merck & Co., Inc., Sanofi, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Astellas Pharma India Private Limited, CSL Limited, Emergent BioSolutions Inc., and GlaxoSmithKline plc, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.